1 / 21

Welcome Applicants!! 

Welcome Applicants!! . Morning Report: Thursday, January 26th. GI Bleeding in Infants and Children. Initial Approach. Step 1: ABCs!! Assess hemodynamic status of the patient Orthostatic changes- best indicator of significant blood loss Step 2: Establish severity of bleeding

yoko
Download Presentation

Welcome Applicants!! 

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Welcome Applicants!! Morning Report: Thursday, January 26th

  2. GI Bleeding in Infants and Children

  3. Initial Approach • Step 1: ABCs!! Assess hemodynamic status of the patient • Orthostatic changes- best indicator of significant blood loss • Step 2: Establish severity of bleeding • Coffee ground emesis, melena: lower rate of bleeding • Bright red blood: ?higher rate of bleeding

  4. UGI vs. LGI Bleeding • Step 3: Determine the location of the bleeding • UGI: bleeding above the ligament of Treitz • Hematemesis • LGI: bleeding distal to the ligament of Treitz • Bloody diarrhea • Bright red blood mixed with or coating stool • Hematochezia, melena, or occult blood loss can be due to both UGI or LGI bleeds • Passing NGT can determine if the blood is originating from the UGI tract or LGI tract

  5. Is It Blood? • Simulates bright red blood • Food coloring • Colored gelatin or children’s drinks • Red candy • Beets • Tomato skins • Antibiotic syrups • Simulates melena • Bismuth or iron preparations • Spinach • Blueberries • Grapes • Licorice

  6. Peptic Ulcer Disease in Children

  7. Pathogenesis Cytoprotective factors: Mucous layer Local bicarb secretion Mucosal blood flow Cytotoxic factors: Acid Pepsin Medications Bile acids Infection with H.Pylori

  8. Clinical Presentation • Epigastric abdominal pain • Recurrent vomiting (at least 3x/mo) • Symptoms associated with eating (anorexia/ wt loss) • Pain awakening the child at night • Heartburn • Oral regurgitation • Chronic nausea • Excessive belching/ hiccuping • FHx of PUD, dyspepsia, or IBS

  9. History • Symptoms? • Dietary history? • Specific foods that worsen pain? • Medications? • Alcohol or tobacco use? • Doses of acid-suppressive meds?

  10. Physical Exam • Height, weight and BMI PLOT! • HEENT • Funduscopic exam • OP: aphthous ulcers Crohn’sdz, dental enamel erosion GER, Eating d/o • Lungs • Wheezing GER • Abdomen • Splenomegaly portal HTN • Rectum • Perianal disease Crohn’sdz • Extremities • Clubbing Crohn’sdz, Russell sign Eating d/o

  11. Evaluation • Screening labs • CBC with diff • ESR • LFTs • Electrolytes • Stool for O&P • UA • Endoscopy • Indications • Evidence of GI bleeding • Abnormality on UGI • Odynophagia • Refusal to eat • Persistant unexplained vomiting • Lack of response to medications

  12. Helicobacter pylori Infection

  13. The Basics… • Gram negative bacillus • Transmission fecal-oral, gastric-oral, or oral-oral • *Organism associated with a significant proportion of duodenal ulcers & chronic active gastritis • To a lesser extent, gastric ulcers • Also linked to the development of gastric adenocarcinoma and lymphoma

  14. Epidemiology • 50 % of the world’s population is infected • Most are asymptomatic • Infection most common in developing countries • Incidence 3-10% in developing countries • Incidence 0.5% in industrialized countries • Asian Americans, African Americans and Hispanic individuals living in North America have a prevalence of infection similar to that of a developing country • Ethnic or genetic predisposition?

  15. *Risk Factors • Poor socioeconomic status • Family overcrowding • Child care attendance • Poor hygiene • Living with an infected family member

  16. *Testing • The ideal test does not yet exist! • Endoscopy with biopsies from the prepyloricantrum= gold standard • Histologic identification • Culture • Immunologic detection of H.Pyloriurease • PCR • Urease breath test • Anti-H. Pylori IgG • Stool antigen testing

  17. *Testing • Stool antigen testing • Sensitivity and specificity> 98% • Sample easy to obtain • Less expensive than the urease breath test • The AAP says…don’t test for it if you are not going to treat it!! • Active peptic ulcer disease • History of ulcers • MALT lymphoma or gastric cancer

  18. *Treatment • Goals • Eradicate the organism • Heal the ulcer • Prevent recurrence of infection and the emergence of resistant organisms • Two antimicrobials + PPI • First line: clarithromycin+ Amoxicillin OR metronidazole+ PPI • Alternative (age>8): tetracycline+ metronidazole+ bismuth subsalicylate+ H2 blocker

  19. *Treatment • Length of treatment: 14days • Cure rates 75-90% • To check for eradication, wait 6 weeks-3 months after the completion of therapy • Urease breath test • Stool antigen test

  20. A Question… • A 12 yo boy who has a h/o recurrent abdominal pain presents to your office for an annual health supervision visit. The boy complains of periumbilical pain, unrelated to meals, occuring twice a month and lasting 15 minutes. PE is normal. FOBT is negative. His father, who is a physician, asks if the boy should undergo testing for H. Pylori. Of the following, a TRUE statement about H. Pylori infection is: • A. All children who have positive H. Pylori serologies should undergo endoscopy • B. Antibiotic therapy for H. Pylori is most effective when combined with a PPI • C. H. Pylori is difficult to detect on gastric histology without special immunofluorescent staining • D. H. Pylori infection is less prevalent in children from the developing world • E. H. Pylori organisms rarely develop antibiotic resistance

  21. Thanks for your attention!! Noon Conference: Pseudoasthma, Dr. Pepiak

More Related